Name: Mr. Kamal
Diagnosis: Ischemia Heart Disease
Therapy: Cell-based Gene Therapy (HGF and adipose-derived stem cells)
Conditions before Cell-based Gene Therapy for Ischemic Heart Disease
Mr. Kamal, a 60-year-old businessman from Indonesia, was suffering from ischemic heart disease for over 6 years.
Mr. Kamal applied conventional medications for his ischemic heart disease after his diagnosis. However, his condition was unstable and progressed gradually. He experienced frequent onsets of angina, which worsen at night. He must get up to sit down and use a kind of liquid with treatment effect prescribed by a local hospital when the angina attacked, as this could relieve his pain to some extent. He could not go upstairs except by elevator due to chest distress and short of breath. Angiography revealed that 80% of his coronary artery was blocked and stent therapy was not suitable for his condition. The cardiac enzyme of him was quite high, with a value over 1000. He was recommended by the doctor of his local hospital to have a bypass surgery. Considering the high risks accompanied with the surgery, Mr. Kamal refused the treatment plan and tried to find a treatment approach with lower risks and better treatment effect. At last, Mr. Kamal and his family decided to receive the cell-based gene therapy in China, which was reported with good treatment results in other patients with similar condition like him.
Therapy and Procedure
Cell-based Gene Therapy (HGF and adipose-derived stem cells): 3 intramuscular injections
Conditions after Cell-based Gene Therapy for Ischemic Heart Disease
One week after injections of cell-based gene therapy for his ischemic heart disease, Mr. Kamal got evident improvements. The angina almost disappeared at night. Occasionally, he would feel angina due to over eat at night. Besides, the chest distress and short of breathe conditions also relieved. He could go upstairs with some steps, which was quite hard for him before he had the gene therapy.